These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32988804)

  • 1. Compliance with Fetal Fibronectin Testing at a Canadian Tertiary Care Perinatal Centre.
    Black B; LeBlanc J; Dodds L; Armson BA; Nash CM
    J Obstet Gynaecol Can; 2021 Feb; 43(2):191-196. PubMed ID: 32988804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing compliance with a clinical practice guideline for fetal fibronectin testing and the management of threatened preterm labour: A quality improvement project.
    Dawes LK; Subramoney M; Miller LM; Groom KM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():89-96. PubMed ID: 29275278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of fetal fibronectin testing in clinical practice.
    Cornelissen LGH; van Oostrum NHM; van der Woude DAA; Rolf C; Porath MM; Oei SG; van Laar JOEH
    J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fetal fibronectin for threatened preterm labour in reducing inappropriate interventions.
    Mahomed K; Anwar S; Geer JE; Ballard E; Okano S
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):523-527. PubMed ID: 30393916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
    Chen MX; Dansereau J; Hoag GN
    J Obstet Gynaecol Can; 2020 Aug; 42(8):971-976. PubMed ID: 32345553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the fetal fibronectin test be used by remote dwelling pregnant women to predict the onset of labour at term and delay transfer for birth in regional settings?
    Rumbold A; Kruske S; Boyle J; Weckert R; Putland S; Giles L; Barclay L; Kildea S
    Rural Remote Health; 2013; 13(2):2126. PubMed ID: 23351083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 16. Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
    Stock SJ; Wotherspoon LM; Boyd KA; Morris RK; Dorling J; Jackson L; Chandiramani M; David AL; Khalil A; Shennan A; Hodgetts Morton V; Lavender T; Khan K; Harper-Clarke S; Mol B; Riley RD; Norrie J; Norman J
    BMJ Open; 2018 Apr; 8(4):e020795. PubMed ID: 29674373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients.
    Skoll A; St Louis P; Amiri N; Delisle MF; Lalji S
    J Obstet Gynaecol Can; 2006 Mar; 28(3):206-213. PubMed ID: 16650359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW; Thanh NX; Chari RS; Wilson RD; Janes-Kelley S; Wesenberg JC
    J Obstet Gynaecol Can; 2016 Jul; 38(7):659-666.e6. PubMed ID: 27591351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervicovaginal fetal fibronectin testing in threatened preterm labour--translating research findings into clinical practice.
    Chuileannain FN; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):399-402. PubMed ID: 9890218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
    García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
    Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.